Thus, our modeling results indicate that humoral immunity against only LPS and OMP, regardless of whether established via vaccine or wild-type infection, will not be protective against Shigella. Below, we amend this slightly while exploring the parameter space further with sensitivity analysis to determine whether altering individual immune response rates can increase the effectiveness of an LPS- or OMP-targeted vaccine. The gene discussed is OMP; the disease is infection.